Trials / Completed
CompletedNCT03351686
Tranexamic Acid in Preventing Postpartum Hemorrhage in High Risk Pregnancies During Elective Cesarean Section
The Effect of Tranexamic Acid in Preventing Postpartum Hemorrhage in High Risk Pregnancies During Elective Cesarean Section, a Randomized Controlled Clinical Trial
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 42 Years
- Healthy volunteers
- Not accepted
Summary
postpartum hemorrhage (PPT) represents one of the major causes of maternal mortality . Tranexamic acid is used in many studies in management of PPH in combination with ecobolics. this study aims to evaluate the possible value of the use of tranexamic acid in prevention of postpartum hemorrhage .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tranexamic Acid | Tranexamic acid (Kepron, Amoun, Egypt) was given slowly intravenously over 10 minutes just before the skin incision of elective cesarean section to group A. Tranexamic acid injection was prepared by diluting 1g (10 mL) tranexamic acid into 20 ml of 5% glucose. |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2017-04-15
- Completion
- 2017-04-15
- First posted
- 2017-11-24
- Last updated
- 2017-11-27
Source: ClinicalTrials.gov record NCT03351686. Inclusion in this directory is not an endorsement.